Your browser doesn't support javascript.
loading
Maintaining point of care testing capacity and pandemic preparedness in the post-COVID-19 era.
Rakeman-Cagno, Jennifer L; Persing, David H; Loeffelholz, Michael J.
Afiliación
  • Rakeman-Cagno JL; Scientific Affairs, Public Health Programs, Cepheid, Sunnyvale, CA, USA.
  • Persing DH; Department Pathology, Stanford University, Palo Alto, CA, USA.
  • Loeffelholz MJ; Scientific Affairs, Cepheid, Sunnyvale, CA, USA.
Expert Rev Mol Diagn ; 24(3): 147-151, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37724428
ABSTRACT

INTRODUCTION:

Testing at the point of care (we also refer to the 'point of need'), with rapid, actionable results reported to the patient and provider within hours can impact the individual as well as public health. Faster testing is good for patients and public health outcomes during 'peace time' (outside of the pandemic setting). AREAS COVERED Testing at the point of need was important during the COVID-19 pandemic to meet testing capacity demands, providing actionable results, and for providing testing within communities to increase access for all populations. Resources were acquired and built up dramatically during the pandemic as part of the response. With the end of the COVID-19 public health emergency and transition back to 'peace time' some testing sites have successfully shifted to using this capacity for testing for other critical needs, like sexually transmitted infection (STI) testing, and response to other seasonal diseases and for outbreak response. EXPERT OPINION The increased testing capacity added to handle unprecedented testing volume during the COVID-19 pandemic can be repurposed for other critical infectious diseases during 'peace time' (post-COVID-19 pandemic). This maintains testing capacity for the next pandemic.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Expert Rev Mol Diagn Asunto de la revista: BIOLOGIA MOLECULAR Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Expert Rev Mol Diagn Asunto de la revista: BIOLOGIA MOLECULAR Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos